c-LEcta is a company active in the industrial biotechnology field. We develop enzymes and production strains, which are used for the industrial production of drugs, nutrition and cosmetic products.
c-LEcta is a fully integrated industrial biotechnology company located in Leipzig, Germany. The company currently employs about 50 people and has established itself as leading player in the realization of high-value biotech products for regulated markets, either as in-house developments or in close cooperation with the industry. c-LEcta delivers cost-efficient and sustainable production processes which enable to open new and to better penetrate existing markets. c-LEcta was the first biotech company financed by the HTGF.
Dr. Marc Struhalla
CEO und Gründer
c-LEcta lays foundation for further growth and closes financing round
Info & Contact